FDA NDC Directory · JSON-LD · Markdown
NDC 27808-169 · HUMAN PRESCRIPTION DRUG · SOLUTION
| Labeler / Manufacturer | Tris Pharma Inc |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA214076 |
| Dosage form / route | SOLUTION · ORAL |
| Active ingredients | POTASSIUM CHLORIDE (40 meq/15mL) |
| Marketing started | 20220126 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).